-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 1, Zhongsheng Pharmaceutical issued a corporate announcement.
ZSP1273 is a kind of innovative drug with a clear mechanism of action and independent intellectual property rights developed by Zhongsheng Ruichuang for major sudden infectious diseases - influenza A and human avian influenza
ZSP1273 has a strong broad-spectrum anti-influenza A virus activity in vitro, and its inhibitory ability to various influenza A viruses is significantly better than that of the same target compound and the neuraminidase inhibitor oseltamivir; the in vivo efficacy test is also comparable to the same.
In terms of drug resistance, ZSP1273 also showed obvious advantages
ZSP1273 tablets have completed Phase I and II clinical studies in China.